| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide | 26 | 2023 | 2140 | 4.090 |
Why?
|
| Hemoglobins | 12 | 2018 | 1531 | 1.640 |
Why?
|
| Vasoconstriction | 8 | 2017 | 591 | 1.450 |
Why?
|
| Hypertension, Pulmonary | 8 | 2020 | 1604 | 1.370 |
Why?
|
| Respiratory Therapy | 3 | 2023 | 124 | 1.240 |
Why?
|
| Blood Substitutes | 4 | 2010 | 57 | 1.200 |
Why?
|
| Administration, Inhalation | 16 | 2023 | 1154 | 1.180 |
Why?
|
| Monophenol Monooxygenase | 5 | 2004 | 72 | 1.110 |
Why?
|
| Sciatic Nerve | 3 | 2012 | 627 | 0.880 |
Why?
|
| Nitrogen Dioxide | 2 | 2023 | 536 | 0.780 |
Why?
|
| Wakefulness | 3 | 2020 | 1282 | 0.640 |
Why?
|
| Air | 2 | 2020 | 186 | 0.640 |
Why?
|
| Electricity | 2 | 2020 | 173 | 0.630 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 377 | 0.620 |
Why?
|
| Calcium Hydroxide | 1 | 2018 | 15 | 0.600 |
Why?
|
| Nerve Regeneration | 3 | 2018 | 796 | 0.530 |
Why?
|
| Lung | 9 | 2023 | 10076 | 0.530 |
Why?
|
| Erythrocyte Transfusion | 4 | 2016 | 575 | 0.510 |
Why?
|
| Sheep | 7 | 2020 | 1449 | 0.490 |
Why?
|
| Drug Contamination | 1 | 2016 | 151 | 0.490 |
Why?
|
| MicroRNAs | 4 | 2014 | 3792 | 0.410 |
Why?
|
| Acculturation | 1 | 2014 | 179 | 0.410 |
Why?
|
| Tyrosine | 4 | 2004 | 1425 | 0.410 |
Why?
|
| Oxygen | 7 | 2024 | 4252 | 0.410 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2012 | 21 | 0.400 |
Why?
|
| Blood Preservation | 2 | 2012 | 169 | 0.390 |
Why?
|
| Cardiovascular System | 1 | 2018 | 839 | 0.370 |
Why?
|
| Schwann Cells | 1 | 2012 | 195 | 0.370 |
Why?
|
| Erythrocytes | 4 | 2018 | 2411 | 0.360 |
Why?
|
| Vaccines, Synthetic | 1 | 2012 | 621 | 0.330 |
Why?
|
| Ganglia, Spinal | 1 | 2011 | 529 | 0.310 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2012 | 923 | 0.300 |
Why?
|
| Free Radical Scavengers | 3 | 2015 | 213 | 0.300 |
Why?
|
| Animals | 40 | 2022 | 168965 | 0.280 |
Why?
|
| Vasodilator Agents | 2 | 2009 | 988 | 0.280 |
Why?
|
| Respiration | 4 | 2024 | 1655 | 0.270 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2013 | 1121 | 0.270 |
Why?
|
| Vasoconstrictor Agents | 2 | 2013 | 655 | 0.260 |
Why?
|
| Blood Pressure | 7 | 2017 | 8531 | 0.260 |
Why?
|
| AIDS Vaccines | 1 | 2012 | 900 | 0.260 |
Why?
|
| Polysaccharides | 1 | 2012 | 1020 | 0.250 |
Why?
|
| Endothelium, Vascular | 3 | 2017 | 4424 | 0.250 |
Why?
|
| Vascular Resistance | 3 | 2015 | 939 | 0.250 |
Why?
|
| Hypertension | 5 | 2017 | 8615 | 0.240 |
Why?
|
| Infusions, Intravenous | 4 | 2020 | 2227 | 0.240 |
Why?
|
| Aldehydes | 2 | 2022 | 170 | 0.240 |
Why?
|
| Drug Compounding | 2 | 2004 | 236 | 0.240 |
Why?
|
| Guanylate Cyclase | 2 | 2017 | 206 | 0.230 |
Why?
|
| Bronchodilator Agents | 2 | 2019 | 513 | 0.230 |
Why?
|
| Students | 1 | 2014 | 1744 | 0.220 |
Why?
|
| Electrodes | 2 | 2016 | 612 | 0.220 |
Why?
|
| Acetaldehyde | 1 | 2022 | 39 | 0.210 |
Why?
|
| Propylene Glycol | 1 | 2022 | 30 | 0.210 |
Why?
|
| Temperature | 3 | 2018 | 2232 | 0.210 |
Why?
|
| Enzymes, Immobilized | 1 | 2002 | 53 | 0.200 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2020 | 64 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2016 | 2920 | 0.200 |
Why?
|
| Mice | 24 | 2022 | 81912 | 0.190 |
Why?
|
| Injections, Intravenous | 4 | 2013 | 1377 | 0.190 |
Why?
|
| Luminescence | 1 | 2022 | 108 | 0.190 |
Why?
|
| Glycerol | 1 | 2022 | 274 | 0.190 |
Why?
|
| Rats | 8 | 2012 | 23713 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2012 | 8108 | 0.180 |
Why?
|
| Formaldehyde | 1 | 2022 | 360 | 0.180 |
Why?
|
| Melanoma, Experimental | 1 | 2004 | 557 | 0.180 |
Why?
|
| Spinal Cord Injuries | 2 | 2018 | 927 | 0.170 |
Why?
|
| Cell Movement | 1 | 2012 | 5203 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 3667 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2018 | 108 | 0.150 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4526 | 0.150 |
Why?
|
| Antisickling Agents | 1 | 2018 | 72 | 0.150 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 2212 | 0.150 |
Why?
|
| Hemodynamics | 3 | 2016 | 4186 | 0.150 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 400 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 12 | 2018 | 22361 | 0.140 |
Why?
|
| Hemopexin | 1 | 2017 | 33 | 0.140 |
Why?
|
| Gases | 1 | 2018 | 205 | 0.140 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2018 | 139 | 0.140 |
Why?
|
| Proteins | 1 | 2012 | 6001 | 0.140 |
Why?
|
| Ventricular Pressure | 1 | 2018 | 210 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 152 | 0.140 |
Why?
|
| Cardiac Output | 2 | 2010 | 837 | 0.140 |
Why?
|
| Heart Rate | 2 | 2024 | 4209 | 0.140 |
Why?
|
| Iridium | 1 | 2016 | 30 | 0.140 |
Why?
|
| Heart Arrest | 2 | 2019 | 1516 | 0.140 |
Why?
|
| Axotomy | 2 | 2017 | 71 | 0.130 |
Why?
|
| Disulfides | 1 | 2018 | 462 | 0.130 |
Why?
|
| Haptoglobins | 1 | 2017 | 165 | 0.130 |
Why?
|
| Filtration | 1 | 2016 | 227 | 0.130 |
Why?
|
| Vasodilation | 1 | 2020 | 968 | 0.130 |
Why?
|
| Plasma Gases | 1 | 2015 | 12 | 0.120 |
Why?
|
| Osteopontin | 1 | 2017 | 305 | 0.120 |
Why?
|
| Pyramidal Tracts | 1 | 2017 | 251 | 0.120 |
Why?
|
| Symporters | 1 | 2018 | 363 | 0.120 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 1181 | 0.120 |
Why?
|
| Metals, Heavy | 1 | 2016 | 149 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7868 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2012 | 2931 | 0.120 |
Why?
|
| Motor Skills | 1 | 2017 | 521 | 0.110 |
Why?
|
| Cross-Linking Reagents | 2 | 2010 | 689 | 0.110 |
Why?
|
| Intraocular Pressure | 2 | 2017 | 1304 | 0.110 |
Why?
|
| Trachea | 1 | 2020 | 1095 | 0.110 |
Why?
|
| Capsules | 2 | 2004 | 193 | 0.110 |
Why?
|
| Male | 27 | 2024 | 364203 | 0.110 |
Why?
|
| Metals | 1 | 2018 | 711 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2024 | 5311 | 0.110 |
Why?
|
| Sheep, Domestic | 2 | 2012 | 52 | 0.100 |
Why?
|
| Retinal Neurons | 1 | 2013 | 67 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2006 | 2168 | 0.100 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 856 | 0.100 |
Why?
|
| Triazoles | 1 | 2018 | 903 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3227 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2006 | 6409 | 0.100 |
Why?
|
| Myocardial Reperfusion | 1 | 2013 | 338 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 873 | 0.100 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2012 | 130 | 0.100 |
Why?
|
| Rabbits | 1 | 2018 | 4751 | 0.090 |
Why?
|
| Ferric Compounds | 1 | 2013 | 376 | 0.090 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 18330 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2013 | 423 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4349 | 0.090 |
Why?
|
| Melanoma | 3 | 2004 | 5702 | 0.090 |
Why?
|
| Hyperemia | 1 | 2012 | 223 | 0.090 |
Why?
|
| Shock, Hemorrhagic | 1 | 2012 | 224 | 0.090 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2012 | 172 | 0.090 |
Why?
|
| Cricetulus | 1 | 2012 | 810 | 0.090 |
Why?
|
| Recovery of Function | 2 | 2018 | 2978 | 0.090 |
Why?
|
| Time Factors | 9 | 2017 | 40154 | 0.080 |
Why?
|
| Equipment Design | 1 | 2018 | 3489 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 515 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 1493 | 0.080 |
Why?
|
| CHO Cells | 1 | 2012 | 1376 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1939 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 1065 | 0.080 |
Why?
|
| Optic Nerve | 1 | 2013 | 568 | 0.080 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 393 | 0.080 |
Why?
|
| Cricetinae | 1 | 2012 | 2415 | 0.080 |
Why?
|
| Hypothermia, Induced | 1 | 2014 | 754 | 0.080 |
Why?
|
| Universities | 1 | 2014 | 1004 | 0.080 |
Why?
|
| Sodium Nitrite | 1 | 2008 | 16 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 857 | 0.080 |
Why?
|
| Cause of Death | 1 | 2019 | 3717 | 0.080 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 1749 | 0.080 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2012 | 878 | 0.070 |
Why?
|
| Methemoglobinemia | 1 | 2008 | 45 | 0.070 |
Why?
|
| China | 1 | 2014 | 2394 | 0.070 |
Why?
|
| Nitrites | 2 | 2022 | 156 | 0.070 |
Why?
|
| Inhalation | 1 | 2008 | 143 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1716 | 0.070 |
Why?
|
| Calcinosis | 1 | 2016 | 1481 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1604 | 0.070 |
Why?
|
| Premedication | 1 | 2008 | 245 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 2030 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4280 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2017 | 4143 | 0.070 |
Why?
|
| Hydrogen Sulfide | 1 | 2008 | 148 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 513 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2017 | 3078 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1349 | 0.070 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2013 | 742 | 0.070 |
Why?
|
| HIV-1 | 2 | 2015 | 6951 | 0.070 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 996 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1188 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2004 | 4026 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3837 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 5796 | 0.060 |
Why?
|
| Kinetics | 2 | 2004 | 6287 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 1900 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2012 | 1505 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2014 | 10455 | 0.060 |
Why?
|
| Myocardium | 1 | 2018 | 4765 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2121 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 706 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2721 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5141 | 0.060 |
Why?
|
| Hypotension | 1 | 2010 | 888 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 9551 | 0.060 |
Why?
|
| Respiratory Rate | 1 | 2024 | 179 | 0.050 |
Why?
|
| Humans | 20 | 2024 | 767040 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2662 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3797 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1331 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2015 | 4925 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2006 | 1885 | 0.050 |
Why?
|
| Oxygen Consumption | 2 | 2008 | 1873 | 0.050 |
Why?
|
| Female | 14 | 2024 | 396660 | 0.050 |
Why?
|
| Neurons | 2 | 2018 | 9517 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2008 | 1308 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 418 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13650 | 0.050 |
Why?
|
| Base Sequence | 1 | 2012 | 12414 | 0.050 |
Why?
|
| Nitrates | 1 | 2022 | 259 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2022 | 342 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 17608 | 0.040 |
Why?
|
| Anesthesia | 1 | 2010 | 1595 | 0.040 |
Why?
|
| Cattle | 1 | 2004 | 3813 | 0.040 |
Why?
|
| Hemoglobin, Sickle | 1 | 2018 | 113 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 2478 | 0.040 |
Why?
|
| Polymerization | 1 | 2018 | 154 | 0.040 |
Why?
|
| Forelimb | 1 | 2017 | 116 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 16036 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2013 | 14476 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2906 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1646 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3587 | 0.030 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 5886 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2018 | 393 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9532 | 0.030 |
Why?
|
| Joints | 1 | 2017 | 324 | 0.030 |
Why?
|
| Reflex | 1 | 2017 | 375 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 703 | 0.030 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 51 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2018 | 591 | 0.030 |
Why?
|
| Aerosols | 1 | 2018 | 634 | 0.030 |
Why?
|
| Hindlimb | 1 | 2017 | 513 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9464 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6215 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2014 | 72 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2014 | 146 | 0.030 |
Why?
|
| Interneurons | 1 | 2018 | 592 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2017 | 578 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2017 | 462 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 17097 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1081 | 0.030 |
Why?
|
| Body Weight | 1 | 2004 | 4627 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2264 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 3043 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 1040 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 2012 | 249 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2018 | 1160 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 36582 | 0.030 |
Why?
|
| Phenylenediamines | 1 | 2013 | 89 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15645 | 0.030 |
Why?
|
| Serotonin | 1 | 2017 | 1045 | 0.030 |
Why?
|
| Contrast Media | 2 | 2018 | 5329 | 0.030 |
Why?
|
| Ophthalmoscopy | 1 | 2013 | 172 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2013 | 262 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11513 | 0.030 |
Why?
|
| Adult | 5 | 2024 | 223317 | 0.020 |
Why?
|
| Methemoglobin | 1 | 2011 | 25 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2015 | 663 | 0.020 |
Why?
|
| Superoxides | 1 | 2013 | 388 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2013 | 374 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3431 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2017 | 2245 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2015 | 1008 | 0.020 |
Why?
|
| Axons | 1 | 2018 | 1675 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 840 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2016 | 741 | 0.020 |
Why?
|
| Hemolysis | 1 | 2012 | 417 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2018 | 1811 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 1751 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2013 | 911 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1388 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 1446 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 1494 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 724 | 0.020 |
Why?
|
| Longevity | 1 | 2017 | 1083 | 0.020 |
Why?
|
| Survival Rate | 2 | 2014 | 12823 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2017 | 1886 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2394 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1562 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8732 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2887 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2221 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 59980 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 21178 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5875 | 0.020 |
Why?
|
| Glucose | 1 | 2018 | 4341 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6513 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2677 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2018 | 24299 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 4918 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8890 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2105 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9327 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 89046 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 7587 | 0.020 |
Why?
|
| Echocardiography | 1 | 2018 | 5042 | 0.020 |
Why?
|
| Inflammation | 2 | 2016 | 10869 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 780 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2017 | 9660 | 0.010 |
Why?
|
| Calcium | 1 | 2017 | 5792 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4892 | 0.010 |
Why?
|
| Middle Aged | 4 | 2019 | 223233 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3370 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2018 | 6611 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2018 | 12793 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7063 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5754 | 0.010 |
Why?
|
| Heart | 1 | 2014 | 4429 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18401 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15424 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11923 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2016 | 3418 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2013 | 2954 | 0.010 |
Why?
|
| United States | 2 | 2018 | 72971 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11063 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16718 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14672 | 0.010 |
Why?
|
| Stroke | 1 | 2017 | 9746 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 18063 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12158 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 54886 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 74886 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 65295 | 0.000 |
Why?
|
| Brain | 1 | 2014 | 27163 | 0.000 |
Why?
|
| Aged | 1 | 2019 | 171319 | 0.000 |
Why?
|